ArticleThe Journal of dermatology2024

Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study.

Da-Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.